Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1260776

Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats


Gojković, Slaven; Krezić, Ivan; Žižek, Helena; Malekinušić, Dominik; Đurasin, Tajana; Drmić, Domagoj; Vraneš, Hrvoje; Dretar, Vilim; Stilinović, Irma; Horvat, Katarina et al.
Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats // Gastroenterology (New York, N.Y. 1943), 158 (2020), 6(S)
online; konferencija, 2020. str. S-502 doi:10.1016/s0016-5085(20)31931-4 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 1260776 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats

Autori
Gojković, Slaven ; Krezić, Ivan ; Žižek, Helena ; Malekinušić, Dominik ; Đurasin, Tajana ; Drmić, Domagoj ; Vraneš, Hrvoje ; Dretar, Vilim ; Stilinović, Irma ; Horvat, Katarina ; Boban Blagaić, Alenka ; Seiwerth, Sven ; Sikirić, Predrag

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Gastroenterology (New York, N.Y. 1943), 158 (2020), 6(S) / - , 2020, S-502

Skup
Digestive Disease Week

Mjesto i datum
Online; konferencija, 02.05.2020. - 05.05.2020

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
intracranial hypertension ; BPC 157 ; superior sagittal sinus ligation

Sažetak
Aim. In rats with intracranial hypertension (IH), we studied the severe gastric and duodenal lesions along with the severe portal and caval hypertension and aortal hypotension and widespread thrombosis with the superior sagittal sinus (SSS) ligation and central blood flow stasis, the disturbances instantly progress toward the periphery and rapidly perpetuate downhill injurious circle. Recently, as a possible resolving solution, pentadecapeptide BPC 157 therapy, (for review: Curr Pharm Des 2018 ; 24:1990-2001) has been used in alleviating vascular occlusion disturbances, and thereby further applied in rats with the SSS ligation. In rats with inferior caval vein (ICV) occlusion, BPC 157 counteracted venous hypertension and aortal hypotension, and thrombosis formation (Vascul Pharmacol 2018 ; 106:54-66). Likewise, BPC 157 counteracted bile duct ligation- induced liver cirrhosis and portal hypertension (Eur J Pharmacol 2019 ; 847:130-142). Methods. To evaluate IH, we made 2 burr holes in anesthetized rats, each approximately 2 mm laterally from the middle of the sagittal suture, and a 5-0 Vicryl suture was used to make a ligation in the middle of the SSS. Then, we made a single burr hole in the rostral part of the sagittal suture, above the SSS, and cannulated SSS anterior part by Braun intravenous cannules, and measured intravascular pressure, before and after medication (BPC 157 10µg, 10ng/kg, 1 ml/rat given topically at the swollen brain ; or ig or ip, while controls received an equal volume of 0.9% NaCl, topically ; or ig or ip).Portal and caval hypertension and aortal hypotension and thrombosis and gastric and duodenal lesions were assessed as described (Vascul Pharmacol 2018 ; 106:54- 66) at 15 min, 24 h and 48 h following sinus occlusion. Results. As shown (Fig. 1), SSS ligation disturbed pressure in SSS (negative between -26--28 mmHg (healthy) toward positive over 20), induced portal hypertension (healthy 3-5 mm Hg toward over 20 mmHg), caval hypertension (healthy 3-5 mm Hg toward over 20 mmHg) and aortal hypotension (below 80 mmHg) and widespread thrombosis (SSS, portal vein (PV), ICV, superior mesenteric vein (SMV), lineal vein (LV), abdominal aorta (AA)), gastric (7±1 mm(15 min), (10±1 (24 h), (10±2 (48 h)) and duodenal (5±1 mm(15 min), (12±2 (24 h), (11±3 (48 h))lesions. While venography studies (into SSS, external jugular vein, ICV) show collaterals rapid presentation, centrally and peripherally, all BPC 157 regimens rapidly reverse brain swelling, and the consequences of the SSS ligation. SSS, portal, caval and aortal pressure were close to normal. Venous and arterial thrombosis were markedly attenuated. Gastric and duodenal lesions were attenuated (Fig. 2). Conclusion. BPC 157 counteracts IH, and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Gojković, Slaven; Krezić, Ivan; Žižek, Helena; Malekinušić, Dominik; Đurasin, Tajana; Drmić, Domagoj; Vraneš, Hrvoje; Dretar, Vilim; Stilinović, Irma; Horvat, Katarina et al.
Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats // Gastroenterology (New York, N.Y. 1943), 158 (2020), 6(S)
online; konferencija, 2020. str. S-502 doi:10.1016/s0016-5085(20)31931-4 (poster, međunarodna recenzija, sažetak, znanstveni)
Gojković, S., Krezić, I., Žižek, H., Malekinušić, D., Đurasin, T., Drmić, D., Vraneš, H., Dretar, V., Stilinović, I. & Horvat, K. (2020) Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats. U: Gastroenterology (New York, N.Y. 1943), 158 (2020), 6(S) doi:10.1016/s0016-5085(20)31931-4.
@article{article, author = {Gojkovi\'{c}, Slaven and Krezi\'{c}, Ivan and \v{Z}i\v{z}ek, Helena and Malekinu\v{s}i\'{c}, Dominik and \DJurasin, Tajana and Drmi\'{c}, Domagoj and Vrane\v{s}, Hrvoje and Dretar, Vilim and Stilinovi\'{c}, Irma and Horvat, Katarina and Boban Blagai\'{c}, Alenka and Seiwerth, Sven and Sikiri\'{c}, Predrag}, year = {2020}, pages = {S-502-S-503}, DOI = {10.1016/s0016-5085(20)31931-4}, keywords = {intracranial hypertension, BPC 157, superior sagittal sinus ligation}, doi = {10.1016/s0016-5085(20)31931-4}, title = {Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats}, keyword = {intracranial hypertension, BPC 157, superior sagittal sinus ligation}, publisherplace = {online; konferencija} }
@article{article, author = {Gojkovi\'{c}, Slaven and Krezi\'{c}, Ivan and \v{Z}i\v{z}ek, Helena and Malekinu\v{s}i\'{c}, Dominik and \DJurasin, Tajana and Drmi\'{c}, Domagoj and Vrane\v{s}, Hrvoje and Dretar, Vilim and Stilinovi\'{c}, Irma and Horvat, Katarina and Boban Blagai\'{c}, Alenka and Seiwerth, Sven and Sikiri\'{c}, Predrag}, year = {2020}, pages = {S-502-S-503}, DOI = {10.1016/s0016-5085(20)31931-4}, keywords = {intracranial hypertension, BPC 157, superior sagittal sinus ligation}, doi = {10.1016/s0016-5085(20)31931-4}, title = {Pentadecapeptide BPC 157 counteracts intracranial hypertension and thereby, severe portal and caval hypertension and aortal hypotension, widespread thrombosis, gastric and duodenal lesions in rats}, keyword = {intracranial hypertension, BPC 157, superior sagittal sinus ligation}, publisherplace = {online; konferencija} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font